TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 7
Market definition 7
Research highlights 8
Market analysis 9
MARKET VALUE 10
MARKET SEGMENTATION I 11
MARKET SEGMENTATION II 12
FIVE FORCES ANALYSIS 13
Summary 13
Buyer power 14
Supplier power 16
New entrants 17
Substitutes 19
Rivalry 20
LEADING COMPANIES 21
Astellas Pharma 21
Kyowa Hakko Kirin Co., Ltd. 25
Mitsubishi Tanabe Pharma Corporation 29
MARKET FORECASTS 32
Market value forecast 32
APPENDIX 33
Methodology 33
Industry associations 34
Related Datamonitor research 34
Disclaimer 35
ABOUT DATAMONITOR 36
Premium Reports 36
Summary Reports 36
Datamonitor consulting 36
LIST OF TABLES
Table 1: Asia-Pacific biotechnology market value: $ million, 2006–10 10
Table 2: Asia-Pacific biotechnology market segmentation I:% share, by value, 2010 11
Table 3: Asia-Pacific biotechnology market segmentation II: % share, by value, 2010 12
Table 4: Astellas Pharma: key facts 21
Table 5: Astellas Pharma: key financials ($) 22
Table 6: Astellas Pharma: key financials (¥) 23
Table 7: Astellas Pharma: key financial ratios 23
Table 8: Kyowa Hakko Kirin Co., Ltd.: key facts 25
Table 9: Kyowa Hakko Kirin Co., Ltd.: key financials ($) 26
Table 10: Kyowa Hakko Kirin Co., Ltd.: key financials (¥) 26
Table 11: Kyowa Hakko Kirin Co., Ltd.: key financial ratios 27
Table 12: Mitsubishi Tanabe Pharma Corporation: key facts 29
Table 13: Mitsubishi Tanabe Pharma Corporation: key financials ($) 30
Table 14: Mitsubishi Tanabe Pharma Corporation: key financials (¥) 30
Table 15: Mitsubishi Tanabe Pharma Corporation: key financial ratios 30
Table 16: Asia-Pacific biotechnology market value forecast: $ million, 2010–15 32
LIST OF FIGURES
Figure 1: Asia-Pacific biotechnology market value: $ million, 2006–10 10
Figure 2: Asia-Pacific biotechnology market segmentation I:% share, by value, 2010 11
Figure 3: Asia-Pacific biotechnology market segmentation II: % share, by value, 2010 12
Figure 4: Forces driving competition in the biotechnology market in Asia-Pacific, 2010 13
Figure 5: Drivers of buyer power in the biotechnology market in Asia-Pacific, 2010 14
Figure 6: Drivers of supplier power in the biotechnology market in Asia-Pacific, 2010 16
Figure 7: Factors influencing the likelihood of new entrants in the biotechnology market in Asia-Pacific, 2010 17
Figure 8: Factors influencing the threat of substitutes in the biotechnology market in Asia-Pacific, 2010 19
Figure 9: Drivers of degree of rivalry in the biotechnology market in Asia-Pacific, 2010 20
Figure 10: Astellas Pharma: revenues & profitability 24
Figure 11: Astellas Pharma: assets & liabilities 24
Figure 12: Kyowa Hakko Kirin Co., Ltd.: revenues & profitability 27
Figure 13: Kyowa Hakko Kirin Co., Ltd.: assets & liabilities 28
Figure 14: Mitsubishi Tanabe Pharma Corporation: revenues & profitability 31
Figure 15: Mitsubishi Tanabe Pharma Corporation: assets & liabilities 31
Figure 16: Asia-Pacific biotechnology market value forecast: $ million, 2010–15 32
[Inhaltsverzeichnis ausblenden]
